WHO-GMP Certified Facility

Authorised Import Gateways Drugs India: 10 New Proposed

CPPL / Blog / Authorised Import Gateways Drugs India: 10 New Proposed
authorised import gateways drugs india

Authorised Import Gateways Drugs India: 10 New Proposed

India Proposes 10 More Authorised Drug Import Gateways: What Changes for Importers

Authorised import gateways drugs India policy is about to change. On November 3, 2026, the Union Health Ministry proposed adding 10 new entry points through which drugs, medical devices and cosmetics can be imported into the country. The proposal amends Rule 43A of the Drugs Rules, 1945. It is still a proposal, and none of the reports we reviewed says when it will be final. This guide lists the 10 locations, explains how the current system works, and sets out what importers and API buyers should check.

This is a plain-English summary of news reports on the proposal, dated where possible. We have not seen the gazette notification itself. It is not legal or regulatory advice, so confirm details with your customs broker and regulatory team.

The Quick Answer

  • What was proposed: 10 new gateways: eight inland container depots (ICDs), one special economic zone (SEZ) and one airport.
  • Which rule: Rule 43A of the Drugs Rules, 1945, which says drugs can be imported only through listed entry points.
  • Why: The ministry says importers could clear consignments closer to their factories, warehouses and distribution centres, which should cut inland transport distance, logistics cost and delay.
  • Status: Proposed amendment. Stakeholders can send objections and suggestions to the Under Secretary (Drugs Regulation) at the Health Ministry. The reports we reviewed do not state a deadline.
  • What it does not say: The coverage does not mention APIs or bulk drugs specifically, and does not report any change to licensing or quality rules.

The 10 Proposed Gateways

According to The Week/PTI, BioSpectrum and Maritime Gateway, the proposed additions are:

State Proposed gateway Type
Haryana Sonipat ICD
Haryana Piyala ICD
Haryana Harsaru ICD
Uttar Pradesh Dadri ICD
Uttar Pradesh Noida International Airport Airport (air imports of drugs)
Gujarat Gandhidham/Mundra ICD
Telangana Sanath Nagar, Hyderabad ICD
Telangana Thimmapur, Hyderabad ICD
Karnataka Whitefield, Bengaluru ICD
Karnataka Bommasandra SEZ

Spellings of some place names differ between outlets. Check the exact names in the gazette notification.

Authorised Import Gateways Drugs India Uses Today

Rule 43A of the Drugs Rules says no drug may be imported into India except through the places it lists. In October 2025, CDSCO reminded stakeholders of this rule, saying drug shipments may enter only through notified ports and that those ports are mapped to CDSCO port offices on ICEGATE, the customs electronic gateway (Medical Dialogues).

The reported process works like this:

  1. The importer files a Bill of Entry on ICEGATE.
  2. The consignment is referred to the relevant CDSCO port office.
  3. The office issues a No Objection Certificate. Officers may inspect labelling, draw samples or send samples for testing.

On July 8, 2026, the government added Navi Mumbai Airport through the Drugs (Ninth Amendment) Rules, 2026, which took the network of notified entry points from 41 to 42 (ThePrint/PTI, Policy Edge). Existing examples include Mumbai Port, Nhava Sheva, Chennai Port and the Delhi Air Cargo Complex, plus the Dhannad and Tihi ICDs in Indore. If all 10 new gateways were approved and nothing else changed, the total would reach 52. That sum is ours, not a figure from the reports.

What the Ministry Says the Change Will Do

The ministry’s stated aims, as reported:

  • Let importers clear consignments nearer to their factories, warehouses and distribution centres.
  • Shorten inland transport distances and lower logistics costs.
  • Reduce delays in moving imported medicines, medical devices and cosmetics.
  • Improve regional availability of imported products.

The reports give no data to back these expectations, and none quotes industry reaction. Our reading, which is an inference, is that the benefit would depend on whether a CDSCO port office is in place at each new gateway, since clearance runs through those offices.

Do the Gateways Cover APIs?

The reports on this proposal say “drugs”, “medicines”, “medical devices” and “cosmetics”. None names active pharmaceutical ingredients (APIs) or bulk drugs. The Policy Edge piece on the Navi Mumbai addition does name APIs among regulated drug products that use these gateways, but it is a secondary analysis and does not quote the rule text for that point.

If you import APIs, intermediates or other raw materials, ask your customs broker whether your products fall under Rule 43A and whether your import documents name specific ports. Do not assume either way.

What Is Still Unknown

Be careful with claims you may see elsewhere:

  • The notification details. The reports give no gazette date or number.
  • The objection deadline. None is stated in the coverage we reviewed.
  • The final list. Proposed locations can change before the rule is final.
  • CDSCO port office coverage. No report says which new gateways will have one or when.
  • Impact on costs. The savings are the ministry’s expectation, not a measured figure.

What It Could Mean for Importers and API Buyers

Possible benefits

  • More choice of entry point could mean shorter inland haulage for consignments going to factories or warehouses in the states named.
  • Importers in Haryana, Uttar Pradesh, Telangana and Karnataka may see the most direct change, since each state gets new gateways.
  • Gandhidham/Mundra adds a Gujarat ICD to the list.

Things to watch

  • Clearance still needs a Bill of Entry, CDSCO referral and a No Objection Certificate. The proposal changes where this happens, not whether it happens.
  • A new gateway helps only once it is operational for drug consignments.
  • Customs brokers and freight forwarders will need to update their routing and documentation.

A Practical Checklist for Importers

  1. Match the list to your supply chain. See which proposed gateways are closer to your factory, warehouse or distributor than your current port.
  2. Wait for the final notification. Do not re-route shipments on the strength of a proposal.
  3. Check your documents. Ask whether your import licence, registration or purchase terms refer to a named port.
  4. Ask about CDSCO coverage. Confirm that a CDSCO port office will handle clearance at the gateway you plan to use.
  5. Talk to your broker. Ask how consignments will be referred on ICEGATE at a new gateway.
  6. Plan for sampling. Officers may inspect labels or draw samples, so keep labelling, CoAs and documents consistent with the Bill of Entry.
  7. Consider commenting. Suggestions can be sent to the Under Secretary (Drugs Regulation) at the Health Ministry.
  8. Track the gazette. Watch for the final notification, the effective date and any change to the list.

Chemox Pharma’s Perspective

Chemox Pharma is a WHO-GMP certified manufacturer of APIs and intermediates, with its own facility and in-house R&D centre in Dahej, Gujarat. This proposal concerns drugs entering India, so it matters most to importers and to formulators that buy imported inputs. We follow it because it is part of the wider push to make drug logistics easier. Material made in India and sold domestically does not go through import clearance at all, which is one reason some buyers weigh local sourcing. For context on that debate, read our guides to India vs China API supply and why the Indian API industry is a global hub in 2026. If you are reviewing sourcing, our team can discuss the APIs and intermediates we offer and the documentation for your product. Availability varies by product, so please confirm details with us directly.

Request a Quote and Documentation

If you are sourcing APIs or intermediates and want to discuss supply and documentation, send us your product list and target markets and contact Chemox Pharma for a quote.

FAQs

Q: What are authorised import gateways for drugs in India?

They are the ports, airports, land stations, ICDs and other entry points listed in Rule 43A of the Drugs Rules, 1945, through which drugs can be imported. Drug consignments are referred to the CDSCO port office at the entry point for clearance.

Q: How many new gateways has India proposed?

Ten: eight inland container depots, one special economic zone and one airport. They are in Haryana, Uttar Pradesh, Gujarat, Telangana and Karnataka.

Q: How many authorised drug import gateways does India have now?

The government said in July 2026 that the total had reached 42 after Navi Mumbai Airport was added. The 10 proposed additions are not yet final.

Q: Which rule is being amended?

Rule 43A of the Drugs Rules, 1945.

Q: Does the proposal affect APIs and bulk drugs?

The reports on the proposal do not mention APIs or bulk drugs. If you import them, confirm with your customs broker whether Rule 43A applies to your products and wait for the final notification.

Leave a Reply

Your email address will not be published. Required fields are marked *